Please login to the form below
NHS at 70
This page shows the latest NHS at 70 news and features for those working in and with pharma, biotech and healthcare.
The NHS at 70: celebrations, renewed reforms and difficult choices
At 70, its apparent that the NHS – like most who reach that age – isn’t in perfect health. ... NHS England chief executive Simon Stevens was interviewed on the BBC’s Today programme (pictured here at the BBC with the original NHS leaflet) this
Latest news
-
Daily Brief: Health and social care still divided, Opdivo rejected in bladder cancer, Xalkori extends reach
This is in line with NHS England's plan to create I ntegrated Care Organisations to provide seamless services to patients. ... NHS. This is a major setback for BMS in England, as its main immunotherapy rival, MSD’s Keytruda was approved in the same
-
NHS bracing for 'no deal’ Brexit impact, including medicines
Safeguarding medical supplies is the top priority, he said, adding that there is “extensive work” underway between the NHS, government, the pharma industry to prepare for ‘no deal’. ... Last week, to mark the NHS’ 70. th. anniversary,
-
Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash
care are far higher than those normally considered an acceptable use of NHS resources. ... NHS budget increase isn’t enough, warns spending watchdog. Just days ahead of the NHS reaching its 70th birthday on 5 July, the head of the National Audit Office,
Daily Brief: Health and social care still divided, Opdivo rejected in bladder cancer, Xalkori extends reach
NHS bracing for 'no deal’ Brexit impact, including medicines
Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash
More from news
Approximately 4 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
New models of NHS care – new models of pharma response?
At PME and IQVIA’s roundtable event, leaders discuss how industry needs to adapt to help an NHS undergoing transformational change. ... Speakers from the NHS and pharma at the recent PME and IQVIA roundtable agreed that pharma could play a role –
-
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe. ... Our health system is at a pivotal point and we have a once in a generation
-
Happy 70th birthday NHS: the next 70 need to be very different
was launched to mark the special anniversary, and took a dispassionate look at the strengths and weaknesses of the NHS. ... Also 70 years old this year is the social care system, but this isn’t understood or loved in the same way as the NHS.
-
The NHS and ABPI at 70: inching closer to the triple win
The NHS reaches the grand old age of 70 this summer, having first opened its doors on 5 July 1948. ... Against this background, solving the problem of how to make the NHS sustainable for the next ten years - let alone the next 70 - is a very present
New models of NHS care – new models of pharma response?
In conversation with Pfizer’s Erik Nordkamp
Happy 70th birthday NHS: the next 70 need to be very different
The NHS and ABPI at 70: inching closer to the triple win
More from intelligence
Approximately 4 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
-
Events Executive
-
Depending on Experience
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
-
Digital account director
-
Competitive
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Understanding the ‘real world’ starts and ends with the patient
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- J&J and Pfizer quietly resolve Remicade biosimilar lawsuit
- CONGREGO™ IS NOW MULTI-PLATFORM
- Onyx Health Marks Record Growth with Six New Appointments
- FDA expands use of COVID-19 antibody cocktail
- New European supply deals show Pfizer and Moderna have increased COVID-19 vaccine prices
- Ipsen’s spending spree bolsters neurology pipeline
- AMICULUM® launches Cence, a new specialist publications agency
- The future of office working designed with our people in mind: ‘Work Where You Work Best’, an Evoke KYNE model
- GSK, Vir’s sotrovimab cuts hospitalisation and death risk by 79% in COVID-19 outpatients
- Biogen and Ionis post ‘encouraging’ early results for Alzheimer’s disease candidate
- Eylea set to challenge Lucentis in UK after NICE recommendation
- Onyx Health Launch Creative Studio After Record Year
- BioNTech to use mRNA technology to develop a ‘highly effective’ malaria vaccine
PMHub
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...
Latest intelligence
- Guide
- How to embrace behavioural science principles in healthcare MR...
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
